| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6278747 | Neuroscience | 2006 | 11 Pages |
Abstract
Taken together, these data suggest that the TREK/TRAAK K-channel family may be a promising target for neuroprotection, and that riluzole and alpha-linolenic acid could be of therapeutic value against focal ischemia/reperfusion injury to the brain.
Keywords
TRAAKTREKMCApCO2TTCALAMABPPO2MCAO2,3,5-triphenyltetrazolium chloridealpha-linolenic acidPolyunsaturated fatty acidsmiddle cerebral artery occlusionFocal ischemialong-term survivalanalysis of varianceANOVATUNELriluzolemiddle cerebral arteryPartial pressure of oxygenPartial pressure of carbon dioxidemean arterial blood pressureNeuroprotectionPalmPalmitic acid
Related Topics
Life Sciences
Neuroscience
Neuroscience (General)
Authors
C. Heurteaux, C. Laigle, N. Blondeau, G. Jarretou, M. Lazdunski,